Free Trial

GoHealth (GOCO) Projected to Post Earnings on Thursday

GoHealth logo with Finance background

Key Points

  • GoHealth is set to announce its Q2 2025 earnings on August 14th, with analysts predicting a loss of ($2.60) per share for the quarter.
  • The company reported a previous quarterly loss of ($0.47) EPS, missing estimates and showing a net margin of 0.23%.
  • Royal Bank Of Canada has maintained a "sector perform" rating on GoHealth, with a target price of $18.00, while Wall Street Zen downgraded the stock to "sell".
  • Need Better Tools to Track GoHealth? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

GoHealth (NASDAQ:GOCO - Get Free Report) is expected to be announcing its Q2 2025 earnings results before the market opens on Thursday, August 14th. Analysts expect the company to announce earnings of ($2.60) per share for the quarter.

GoHealth (NASDAQ:GOCO - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.21). GoHealth had a net margin of 0.23% and a negative return on equity of 7.10%. The firm had revenue of $220.97 million during the quarter, compared to analysts' expectations of $225.91 million. On average, analysts expect GoHealth to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

GoHealth Stock Performance

NASDAQ:GOCO opened at $6.31 on Thursday. The company has a market capitalization of $149.79 million, a P/E ratio of -5.26 and a beta of 1.49. The business has a fifty day simple moving average of $5.87 and a two-hundred day simple moving average of $10.26. The company has a debt-to-equity ratio of 1.60, a current ratio of 1.12 and a quick ratio of 1.12. GoHealth has a 1 year low of $5.01 and a 1 year high of $21.00.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Royal Bank Of Canada reiterated a "sector perform" rating and issued a $18.00 target price on shares of GoHealth in a research note on Monday, May 19th. Wall Street Zen lowered shares of GoHealth from a "hold" rating to a "sell" rating in a research note on Friday, July 18th.

Check Out Our Latest Research Report on GoHealth

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE lifted its position in GoHealth by 22.8% in the 4th quarter. Bank of America Corp DE now owns 7,831 shares of the company's stock worth $105,000 after buying an additional 1,452 shares during the last quarter. Cubist Systematic Strategies LLC lifted its holdings in shares of GoHealth by 297.3% in the 1st quarter. Cubist Systematic Strategies LLC now owns 10,915 shares of the company's stock worth $134,000 after acquiring an additional 8,168 shares during the last quarter. Jane Street Group LLC bought a new position in shares of GoHealth during the 1st quarter valued at $177,000. Finally, Empowered Funds LLC raised its position in GoHealth by 7.7% in the 1st quarter. Empowered Funds LLC now owns 25,008 shares of the company's stock worth $307,000 after purchasing an additional 1,790 shares during the period. 24.21% of the stock is currently owned by hedge funds and other institutional investors.

About GoHealth

(Get Free Report)

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.

Featured Articles

Earnings History for GoHealth (NASDAQ:GOCO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in GoHealth Right Now?

Before you consider GoHealth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GoHealth wasn't on the list.

While GoHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines